ArticleCancer research communications2026
A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor-Positive Metastatic Breast Cancer.
Alberto A Gabizon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.